Skip to content

DYN DYNE THERAPEUTICS INC

Follow

Stock (common), issuer CIK 1818794

204 managers (206 13F filers) reported a position in DYN shares at 2025-03-31, 122,010,700 shares in all. 47 filers opened a position and 43 filers sold out during the quarter.

Managers
204
13F filers
206
New
47
Added
81
Reduced
44
Sold out
43
Shares held by filers
122,010,700

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

The latest Form 4 transactions, non-derivative.
OwnerDateSharesPriceFiling
Posner Brian Sdirector2026-10-02+2,500 P$16Form 4

13F holders, Q1 2025

Filers in the available 13F reports with a share position at 2025-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Federation des caisses Desjardins du Qu…20$209<0.01%013F-HRTimeline
Amundiin group Amundi21$198<0.01%013F-HRTimelineGroup
NATIONAL BANK OF CANADA /FI/in group NATIONAL BANK OF CANADA /FI/1$10<0.01%new13F-HRTimelineGroup
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$0013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.

Events

  • Posner Brian S bought 2,500 DYN shares on 2026-10-02, Form 4 filed 2026-10-06. 0001193125-26-415584

    Accepted , ingested